← Oncology Approval Tracker

FDA DECISION ·

Pralatrexate (Folotyn reference)

pralatrexate · Dr. Reddy’s Laboratories

First generic approvalFirst genericPeripheral T-cell lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic pralatrexate injection for relapsed or refractory peripheral T-cell lymphoma.

LAMPGEN ANALYSIS

Why it matters

The approval added an alternative source for an antifolate used in recurrent peripheral T-cell lymphoma.

What research teams should watch

Keep vitamin supplementation, blood count monitoring, and mucositis checks in the infusion workflow across suppliers.

PRIMARY RECORDS

Sources